Adage Capital Partners Gp, L.L.C. Novartis Ag Transaction History

Adage Capital Partners Gp, L.L.C.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $6.76 Million - $7.69 Million	-70,923 Reduced 17.98%	323,549 $31.3 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $7.61 Million - $8.38 Million	82,500 Added 26.44%	394,472 $39.8 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $6.97 Million - $7.73 Million	73,564 Added 30.86%	311,972 $31.8 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $9.85 Million - $11.2 Million	106,424 Added 80.63%	238,408 $24.1 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $10.6 Million - $12.2 Million	131,984 New	131,984 $12.1 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $8.83 Million - $12.4 Million	-125,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $10.5 Million - $11.9 Million	125,000 New	125,000 $11.8 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $7.54 Million - $9.28 Million	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $7.53 Million - $8.62 Million	-100,000 Reduced 50.0%	100,000 $9.61 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $14.7 Million - $16.4 Million	200,000 New	200,000 $17.2 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.